Recent Updates
Recently added Catalysts
KYMR Positive Sentiment

Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7

Wednesday, July 31, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Kymera Therapeutics, a clinical-stage biopharmaceutical company, will report its second quarter 2024 financial results on August 7, 2024. The company focuses on developing small molecule medicines through targeted protein degradation (TPD). Investors can participate in a conference call at 8:30 a.m. ET on the reporting date. Additionally, a live webcast will be available on the company's website, with a replay afterwards.
Price reaction · baseline $43.11 (2024-07-30 close) · hit after-hours · clean, no other KYMR news in the window
day 0 close
+7.2%
day 1
+3.2%
day 3 · peak
-8.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics is advancing a new class of medicines using TPD.
  • The scheduled financial report may indicate growth or positive developments.
  • Hosting a conference call shows transparency and engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+111%
120-day peak, hindsight
Typical move
4.3%
average across 7 past catalysts
Cash runway
~83 mo
Minimal dilution risk
Lead asset
KT-621
Phase 2 · Atopic Dermatitis

Full Press Release Details

Watertown, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), will report second quarter 2024 financial results on August 7, 2024, and will host a conference call at 8:30 a.m. ET.
To access the August 7 conference call via phone, please dial +1 (833) 630-2127 (US) or +1 (412) 317-1846 (International) and ask to join the Kymera Therapeutics call. A live webcast of the Company’s conference call will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.
About Kymera Therapeutics

Frequently Asked Questions

When will Kymera Therapeutics report Q2 2024 financial results?

Kymera Therapeutics will report its second quarter 2024 financial results on August 7, 2024.

What time is the conference call for Kymera's Q2 results?

The conference call is scheduled for 8:30 a.m. ET on August 7, 2024.

How can I access the Kymera Therapeutics conference call?

Access the call by dialing +1 (833) 630-2127 for US or +1 (412) 317-1846 internationally.

Will there be a live webcast for the conference call?

Yes, a live webcast will be available on Kymera's website under 'News and Events.'

Is there a replay available for the conference call?

A replay of the webcast will be archived and accessible after the event.

ShareAdd on Google
Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics Q2 2024 financial results targeted protein degradation biopharmaceutical
Last updated: Jul 31, 2024

Biotech snapshot

Cash runway
$1505M liquidity · $18M/mo burn
~83 mo
Minimal dilution risk
Lead asset
KT-621Phase 2
Atopic Dermatitis →

Catalyst track record

+111%
best trade around KYMR's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for KYMR.

See every catalyst's timing & PoA →